Alpha-1-Antitrypsin Quantitation, commonly referred to as the AAT Test, is a diagnostic procedure designed to measure the levels of alpha-1-antitrypsin (AAT) in the blood. AAT is a protein produced by the liver, playing a critical role in protecting the lungs from the harmful effects of other enzymes in the body. Abnormal levels of AAT can indicate a genetic condition known as Alpha-1 Antitrypsin Deficiency, which can lead to lung and liver diseases.
The AAT Test is particularly vital for individuals experiencing unexplained lung problems, such as shortness of breath, wheezing, or chronic obstructive pulmonary disease (COPD), especially if they occur without a history of risk factors like smoking. It's also recommended for individuals with liver disease of unknown cause or those with a family history of Alpha-1 Antitrypsin Deficiency.
In the UAE, the AAT Test is available at DNA Labs, a leading diagnostic center known for its advanced medical testing services. The cost of the test at DNA Labs UAE is 470 AED. This price includes a comprehensive analysis to accurately quantify the levels of alpha-1-antitrypsin in the blood, providing essential information for diagnosis, treatment planning, and management of conditions associated with AAT deficiency.
The "Aluminium Dialysis Fluid Test" is a specialized diagnostic procedure aimed at measuring the levels of aluminium in the dialysis fluid used in the treatment of patients with kidney failure. This test is crucial as elevated levels of aluminium can lead to significant health complications, including bone diseases, anemia, and encephalopathy, particularly in patients undergoing long-term dialysis.
Conducted at DNA Labs UAE, a leading facility known for its advanced diagnostic services, this test ensures the safety and efficacy of the dialysis fluid, thereby protecting patients from potential aluminium toxicity. The test cost is set at 470 AED, reflecting the intricate processes involved in accurately assessing the aluminium levels and the expertise required to interpret the results. By providing this service, DNA Labs UAE plays a vital role in the maintenance of high-quality standards in dialysis treatment, contributing to the overall health and well-being of patients with renal failure.
The Aluminium Plasma Test is a specialized diagnostic procedure aimed at measuring the levels of aluminium in the blood. This test is particularly crucial for individuals who are at risk of aluminium exposure through their environment or occupation, as well as for those with certain medical conditions that might affect aluminium absorption and elimination. Elevated levels of aluminium in the blood can be indicative of excessive exposure or compromised renal function, leading to potential health issues such as neurotoxicity.
At DNA Labs UAE, this test is offered for a cost of 470 AED. DNA Labs UAE is a reputable facility known for its advanced testing methods and accurate results. The lab employs state-of-the-art technology and adheres to stringent quality control measures to ensure the reliability of its tests. Conducting the Aluminium Plasma Test at DNA Labs UAE provides patients and healthcare providers with critical information that can guide treatment decisions and help in monitoring and managing potential exposure to aluminium.
The Aluminium Serum Test is a diagnostic procedure conducted to measure the levels of aluminium in the blood. Aluminium, a common metal found in the environment, can enter the human body through various sources including food, drinking water, and certain medications. While small amounts of aluminium are normally present in the body, elevated levels can be toxic and may indicate excessive exposure or impaired elimination of the metal.
This test is particularly important for individuals who may be at risk of aluminium toxicity, such as those with kidney impairments or workers in industries where aluminium exposure is high. Symptoms of aluminium toxicity include confusion, muscle weakness, bone pain, and anemia, among others.
At DNA Labs UAE, the Aluminium Serum Test is available for a cost of 470 AED. The lab utilizes advanced testing methodologies to ensure accurate and reliable results. The test process involves collecting a small sample of the patient's blood, which is then analyzed to determine the aluminium concentration. Results from this test can help healthcare providers assess exposure levels and guide treatment decisions to manage or mitigate the effects of aluminium toxicity.
The "Analyzer 26 SMA 26 Test Panel Test" is a comprehensive diagnostic tool offered by DNA Labs UAE, designed to screen for Spinal Muscular Atrophy (SMA) among other conditions. SMA is a genetic disorder characterized by weakness and wasting (atrophy) in muscles used for movement. This test panel utilizes advanced analytical techniques to examine specific genetic markers associated with SMA, providing insights into the individual's genetic predisposition to this condition.
The test is conducted in a state-of-the-art laboratory setting by DNA Labs UAE, a leading provider of genetic testing services in the region. The process involves collecting a DNA sample from the patient, usually through a blood draw or a cheek swab, which is then analyzed using sophisticated genetic sequencing and analysis technologies.
The cost of the "Analyzer 26 SMA 26 Test Panel Test" is 470 AED. This price reflects the comprehensive nature of the test and the advanced technology used in the analysis. Patients considering this test can expect a reliable assessment of their genetic risk for SMA, which can be crucial for early diagnosis, treatment planning, and family planning decisions.
It's important for patients to consult with a healthcare provider or a genetic counselor before and after undergoing genetic testing to understand the implications of the results and to receive personalized advice based on their specific health profile and family history.
The Anti Nuclear Antibody (ANA) test, also known as ANF (Antinuclear Factor) test, is a crucial diagnostic tool used to detect autoimmune diseases. This test specifically identifies antibodies in the blood that target substances within the nucleus of cells, signaling an autoimmune reaction. The ANA test is often conducted through an Indirect Fluorescent Antibody (IFA) technique, utilizing HEp-2 cells as a substrate. This method is highly sensitive for the detection of antinuclear antibodies, making it a preferred choice in clinical diagnostics.
The HEp-2 IFA test is particularly valuable because it not only confirms the presence of antinuclear antibodies but also allows for the determination of the antibody's end point titre. This is significant as the titre level can provide insights into the severity and progression of the autoimmune disorder. A higher titre value often correlates with more active or widespread disease.
In the UAE, this important test is available at DNA Labs, a reputable diagnostic center known for its advanced testing capabilities and accurate results. The cost of the ANA (ANF IFA HEp-2 End Point Titre) Test at DNA Labs UAE is 470 AED. This price reflects the comprehensive nature of the test, including the sophisticated IFA technique and the detailed analysis required to determine the antibody titre levels. Patients undergoing this test at DNA Labs UAE can expect high-quality service and reliable results, aiding in the effective management of autoimmune diseases.
The Breast Monitor Panel Test, available at DNA Labs UAE for 470 AED, is a specialized diagnostic tool designed to assess an individual's risk for breast cancer by analyzing specific genetic markers and indicators associated with the disease. This comprehensive test aims to provide a detailed insight into the genetic predispositions that might increase the likelihood of developing breast cancer, enabling individuals to take proactive steps towards prevention or early detection. By evaluating a range of genetic factors, the Breast Monitor Panel Test serves as a crucial resource for those with a family history of breast cancer or anyone seeking to understand their personal risk profile. Conducted in the state-of-the-art facilities of DNA Labs UAE, this test represents a critical step forward in personalized medicine and breast cancer prevention strategies.
Immunophenotyping by Flow Cytometry CD23 Test is a specialized diagnostic procedure utilized to identify and quantify the presence of CD23 antigen on the surface of cells, particularly B lymphocytes, within a blood or tissue sample. CD23, also known as the low-affinity receptor for IgE (Fc epsilon RII), plays a critical role in various immune responses and is involved in the regulation of IgE levels. This test is instrumental in the diagnosis and monitoring of certain hematological disorders, including chronic lymphocytic leukemia (CLL) and other B-cell malignancies, where CD23 expression can be markedly increased or altered.
Performed at DNA Labs UAE, a leading diagnostic and research facility, the Immunophenotyping by Flow Cytometry CD23 Test leverages the precision of flow cytometry technology. This advanced technique enables the rapid and accurate analysis of thousands of cells in a sample, providing detailed information on cell size, granularity, and the presence of specific cell surface markers like CD23. The test cost is 480 AED, reflecting the sophisticated nature of the technology and the valuable insights it offers into patient health and disease management.
DNA Labs UAE is equipped with state-of-the-art technology and staffed by highly trained professionals, ensuring that patients and healthcare providers receive reliable, high-quality diagnostic services. The CD23 Test is just one example of the lab's commitment to supporting healthcare through advanced diagnostic solutions.
Immunophenotyping by Flow Cytometry CD3 Test is a sophisticated diagnostic procedure utilized to analyze the different types of cells within a blood sample, focusing specifically on the presence and quantity of CD3+ T cells. This test is particularly valuable in diagnosing and monitoring diseases related to the immune system, such as autoimmune disorders, immunodeficiency states, and certain types of cancers, especially those affecting the lymphoid system.
The CD3 molecule is a defining marker of T lymphocytes, which play a crucial role in the body's immune response. By assessing the levels of CD3+ cells, healthcare providers can gain insights into a patient's immune system status, aiding in the diagnosis, prognosis, and treatment planning of various conditions.
Conducted using the advanced technology of flow cytometry, this test allows for a rapid and accurate analysis of cell populations. During the procedure, a blood sample is treated with fluorescent antibodies that specifically bind to the CD3 molecules. The sample is then passed through a flow cytometer, a device that uses lasers to detect the fluorescently labeled cells, enabling the quantification and characterization of the CD3+ T cells among other cell types present in the sample.
The Immunophenotyping by Flow Cytometry CD3 Test is available at DNA Labs UAE, a leading diagnostic center known for its state-of-the-art facilities and expertise in genetic and molecular testing. The cost of the test is 480 AED, making it an accessible option for those needing detailed insights into their immune system's functioning for accurate medical evaluation and intervention.
Immunophenotyping by Flow Cytometry CD33 Test is a specialized diagnostic procedure performed to identify and analyze cells expressing the CD33 antigen, commonly found on the surface of myeloid cells. This test is crucial in the diagnosis and management of various hematological disorders, including certain types of leukemia, where CD33 expression can be a significant marker for disease identification and progression. The process involves using flow cytometry technology to quantify and categorize cells based on their physical and chemical characteristics, providing detailed insights into the cellular composition of a sample.
At DNA Labs UAE, the Immunophenotyping by Flow Cytometry CD33 Test is available for a cost of 480 AED. The facility employs cutting-edge technology and expertise to ensure accurate and reliable results, aiding in the effective diagnosis and treatment planning for patients with myeloid-related hematological conditions. This test is a valuable tool in the clinical setting, offering critical information that can influence treatment decisions and patient outcomes.
